{"meta":{"query_hash":"f2f3bbffdd32","filters":{"venue":"Hematology/Oncology and Stem Cell Therapy"},"cohort_total":20,"direct_labels_cover":0,"predictions_cover":20,"exported":20,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/f2f3bbffdd32","api":"https://metacan.xera.ac/api/v1/cohort?venue=Hematology%2FOncology+and+Stem+Cell+Therapy"},"results":[{"id":"W1987621661","doi":"10.1016/s1658-3876(09)50041-6","title":"The National Oncology Program","year":2009,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Ontario; London Health Sciences Centre","funders":"","keywords":"General partnership; Medicine; Oncology; Family medicine; Internal medicine; Medical physics; Political science","score_opus":0.017639780555448015,"score_gpt":0.30884220615980107,"score_spread":0.29120242560435305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987621661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9026194,0.03258909,0.0001717829,0.008218206,0.0006693202,0.00093463337,0.000015260695,0.000057036963,0.054725226],"genre_scores_gemma":[0.97738737,0.015968112,0.00064234936,0.004762866,0.00026405478,0.00012359169,0.000027779379,0.000014511242,0.000809377],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988278,0.0001403809,0.0002684923,0.0003403695,0.00008664083,0.00033630742],"domain_scores_gemma":[0.99927056,0.0001977967,0.00013589082,0.00018363363,0.00011917257,0.00009297279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000391989,0.00017224175,0.0002425972,0.00003080755,0.00032725753,0.00002685945,0.00020591255,0.00040197617,0.000010832247],"category_scores_gemma":[0.000020243302,0.00012710103,0.00007662938,0.00006266663,0.0002697273,0.0000028595762,0.000048976908,0.00016272972,0.00001336856],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015585731,0.0011657495,0.0018760794,0.000012840599,0.00016107182,0.000042054817,0.0003592776,0.000022147651,0.07078353,0.032254457,0.05734916,0.8344151],"study_design_scores_gemma":[0.0015121187,0.0035704877,0.0011239187,0.0000023459975,0.000009053059,0.00024018486,0.00013446689,0.000047233218,0.024428787,0.0025768501,0.96617955,0.00017499868],"about_ca_topic_score_codex":0.0000019878887,"about_ca_topic_score_gemma":0.00003364333,"teacher_disagreement_score":0.9088304,"about_ca_system_score_codex":0.000040152645,"about_ca_system_score_gemma":0.00029582993,"threshold_uncertainty_score":0.5183029},"labels":[],"label_agreement":null},{"id":"W2067320607","doi":"10.1016/s1658-3876(08)50065-3","title":"Cyclin D1 positive plasma cell myeloma","year":2008,"lang":"en","type":"letter","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Hospital; Hamilton General Hospital; University of Alberta Hospital; Alberta Hospital Edmonton; University Health Network","funders":"","keywords":"Cyclin D1; Multiple myeloma; Plasma Cell Myeloma; Cancer research; Plasma cell; Cell biology; Chemistry; Medicine; Internal medicine; Biology; Cell cycle; Cancer","score_opus":0.033013270098028825,"score_gpt":0.29931132990877485,"score_spread":0.266298059810746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067320607","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6021047,0.028619962,0.000036059948,0.28964508,0.0014399007,0.0043757,0.000255055,0.00033195876,0.073191576],"genre_scores_gemma":[0.2760921,0.056037914,0.002117253,0.5639389,0.0030302405,0.0011032196,0.0025431071,0.00048516502,0.09465209],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957495,0.00072582817,0.00071230397,0.001143949,0.00044114224,0.0012272923],"domain_scores_gemma":[0.99710673,0.0012616146,0.00039442486,0.00068883866,0.00018368916,0.00036467792],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00021486019,0.000831103,0.002061018,0.00042515507,0.0003875115,0.000022233437,0.00027333281,0.0032956603,0.00042903508],"category_scores_gemma":[0.000010861747,0.0006532928,0.000369545,0.00018549246,0.0007555108,0.00006572601,0.00011107802,0.0028987452,0.0006277092],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034642841,0.0011248902,0.008319911,0.0006033815,0.0010567234,0.06263839,0.001164425,2.0873296e-7,0.0013031134,0.000027357417,0.8997437,0.020553647],"study_design_scores_gemma":[0.016253578,0.004676453,0.0023068688,0.00014912829,0.00020415425,0.011211738,0.00017945628,0.000059866554,0.028367218,0.00008396386,0.9358086,0.0006989548],"about_ca_topic_score_codex":0.000038016628,"about_ca_topic_score_gemma":0.0000105074,"teacher_disagreement_score":0.3260126,"about_ca_system_score_codex":0.00026453062,"about_ca_system_score_gemma":0.00068212044,"threshold_uncertainty_score":0.9995918},"labels":[],"label_agreement":null},{"id":"W2106300172","doi":"10.1016/s1658-3876(08)50042-2","title":"Why implement universal leukoreduction?","year":2008,"lang":"en","type":"review","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Leukoreduction; Computer science; Biology","score_opus":0.029085284061874633,"score_gpt":0.3120599392429594,"score_spread":0.2829746551810848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106300172","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011438369,0.99584234,0.00015699609,0.00013501175,0.0007393067,0.000842795,0.000025560617,0.00003262802,0.0010815026],"genre_scores_gemma":[0.00021460357,0.997302,0.00012892927,0.00020250192,0.00035348022,0.00013194306,0.0004057205,0.0000660689,0.001194728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99771047,0.0004371038,0.0005713269,0.0007711954,0.00010218481,0.00040774836],"domain_scores_gemma":[0.99881744,0.00005704168,0.00046003322,0.00047540752,0.000070706395,0.000119370634],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0001420253,0.000499748,0.001251401,0.00016013779,0.00022770415,0.000010794637,0.00022982998,0.0014534886,0.000079622485],"category_scores_gemma":[0.0000023129144,0.0004462904,0.00035547448,0.0001544644,0.00024771842,0.0000051004176,0.000111170826,0.00032550681,0.000023114333],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016070438,0.00016347767,0.000016635762,0.000905353,0.0006349721,0.000044927183,0.0001247862,0.000005268226,0.0003158923,0.0004079295,0.06128294,0.9359371],"study_design_scores_gemma":[0.0009744342,0.00065336423,0.0000018816703,0.00016082177,0.00013395079,0.002297959,0.00007330994,0.000002452358,0.000836335,0.000020729123,0.99443996,0.00040478166],"about_ca_topic_score_codex":0.000012094446,"about_ca_topic_score_gemma":0.000031267435,"teacher_disagreement_score":0.93553233,"about_ca_system_score_codex":0.00012917895,"about_ca_system_score_gemma":0.00060987525,"threshold_uncertainty_score":0.9998428},"labels":[],"label_agreement":null},{"id":"W2126600663","doi":"10.1016/s1658-3876(09)50036-2","title":"Improved compliance with adjuvant vinorelbine and cisplatin in non-small cell lung cancer","year":2009,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Vinorelbine; Carboplatin; Chemotherapy; Internal medicine; Cisplatin; Oncology; Febrile neutropenia; Neutropenia; Lung cancer; Surgery","score_opus":0.017052164314345166,"score_gpt":0.29504648141162515,"score_spread":0.27799431709728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126600663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9569376,0.0370514,0.00006600821,0.002563768,0.000087469394,0.0010568339,0.0000057334787,0.000029955276,0.0022012277],"genre_scores_gemma":[0.98445535,0.012245471,0.0007435206,0.0018785632,0.000035882396,0.000215527,0.000007833557,0.000019144205,0.00039872143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986985,0.000062527884,0.00030557546,0.0004859856,0.00006909778,0.0003783264],"domain_scores_gemma":[0.9992932,0.00013807202,0.00015002108,0.00022115953,0.000049982038,0.00014758081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012659386,0.00027608356,0.0008051417,0.000088020955,0.0000877755,0.00000976986,0.000060799215,0.00024318049,0.000046554218],"category_scores_gemma":[8.229399e-7,0.00019114968,0.000039445495,0.00012257944,0.00012696284,0.000039879742,0.000017589484,0.00025415336,0.0000023233686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034183303,0.0017148464,0.9109349,0.00058469665,0.00017204015,0.0009772747,0.0025522273,0.000009644539,0.007959717,0.00025687943,0.00074138085,0.07067805],"study_design_scores_gemma":[0.06387104,0.015921587,0.8321771,0.0013438683,0.00047419438,0.0013334497,0.0009777118,0.005828434,0.07348175,0.00017503432,0.00343918,0.0009766519],"about_ca_topic_score_codex":0.00010169369,"about_ca_topic_score_gemma":0.0003528462,"teacher_disagreement_score":0.078757815,"about_ca_system_score_codex":0.00014165223,"about_ca_system_score_gemma":0.00014643194,"threshold_uncertainty_score":0.77948576},"labels":[],"label_agreement":null},{"id":"W2604827614","doi":"10.1016/j.hemonc.2017.02.002","title":"Hydroxyurea for nontransfusion-dependent β-thalassemia","year":2017,"lang":"en","type":"review","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Meta-analysis; Thalassemia; Medicine; Computer science; Internal medicine","score_opus":0.07452914237322243,"score_gpt":0.3737980496350577,"score_spread":0.29926890726183525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604827614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027844758,0.981549,0.00009259536,0.0004325753,0.0009657135,0.003646045,0.00004047337,0.00009283152,0.012902304],"genre_scores_gemma":[0.0002491816,0.99299985,0.00015465476,0.0003021379,0.00015375519,0.00064069504,0.000115562536,0.0001065775,0.005277603],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99717355,0.00024539384,0.00092083093,0.0008372201,0.00015536259,0.00066766905],"domain_scores_gemma":[0.9975842,0.0006167469,0.0006475268,0.00077264424,0.00009302229,0.00028581105],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00057481066,0.0007076268,0.004169832,0.00022694514,0.0005255825,0.000028611683,0.00031274575,0.0030381212,0.0001021101],"category_scores_gemma":[0.000016781936,0.00048344713,0.00079952326,0.00007823108,0.00036167633,0.00004680736,0.000060081722,0.0009895636,0.000072547846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032423116,0.0004103313,0.000050934075,0.012183905,0.000662169,0.00041833372,0.0002298147,6.195281e-8,0.000008651665,0.00054015993,0.0022796888,0.98289174],"study_design_scores_gemma":[0.0042783273,0.0012517701,0.0000026967452,0.0029710273,0.0012377773,0.0029673341,0.0001222008,0.000008529754,0.000030468369,0.00013093138,0.9865605,0.00043840625],"about_ca_topic_score_codex":0.000009153564,"about_ca_topic_score_gemma":0.000011076538,"teacher_disagreement_score":0.9842808,"about_ca_system_score_codex":0.0001086601,"about_ca_system_score_gemma":0.0008308056,"threshold_uncertainty_score":0.9997617},"labels":[],"label_agreement":null},{"id":"W2731774606","doi":"10.1016/j.hemonc.2017.05.016","title":"Establishing an autologous versus allogeneic hematopoietic cell transplant program in nations with emerging economies","year":2017,"lang":"en","type":"review","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Context (archaeology); Transplantation; Medicine; Hematopoietic stem cell transplantation; Health care; Mandate; Accreditation; Hematopoietic stem cell; Hematopoietic cell; Intensive care medicine; Stem cell; Haematopoiesis; Internal medicine; Economic growth; Political science; Biology; Economics","score_opus":0.08610687944668716,"score_gpt":0.3720520217004427,"score_spread":0.28594514225375556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2731774606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01639635,0.96532285,0.0000600019,0.0001479002,0.000518103,0.0041634543,0.000043099473,0.00025870118,0.013089518],"genre_scores_gemma":[0.021767395,0.97439814,0.0014278662,0.000055665158,0.00007300429,0.0013767203,0.00036837484,0.00015249162,0.00038034943],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954734,0.0006934438,0.0014153922,0.0012663469,0.00023601898,0.00091538357],"domain_scores_gemma":[0.9963698,0.0012831223,0.000960966,0.00095668226,0.00008751222,0.00034193552],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007874974,0.00097437017,0.0041689803,0.00089970557,0.00047262004,0.00010712235,0.0005016904,0.0016374497,0.00007484282],"category_scores_gemma":[0.000010204289,0.00076553895,0.00033118136,0.00030945212,0.00051537005,0.00028201332,0.000037594065,0.0011091579,0.000038816703],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020270953,0.0024736128,0.002339237,0.049098197,0.0008752305,0.004763199,0.008553155,0.000008529854,0.000020916263,0.0024143227,0.000049807833,0.9273767],"study_design_scores_gemma":[0.014978346,0.0057315743,0.00011534956,0.011690009,0.0026658066,0.010485646,0.0020315184,0.00006539665,0.0003049349,0.00006876752,0.9501576,0.0017050663],"about_ca_topic_score_codex":0.000027396372,"about_ca_topic_score_gemma":0.00048682024,"teacher_disagreement_score":0.95010775,"about_ca_system_score_codex":0.00022643659,"about_ca_system_score_gemma":0.0011734406,"threshold_uncertainty_score":0.99965864},"labels":[],"label_agreement":null},{"id":"W2892785587","doi":"10.1016/j.hemonc.2018.09.001","title":"Clinical and histopathological spectrum of toxic erythema of chemotherapy in patients who have undergone allogeneic hematopoietic cell transplantation","year":2018,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Hematopoietic cell; Hematopoietic stem cell transplantation; Chemotherapy; Medicine; Erythema; Transplantation; Broad spectrum; Haematopoiesis; Pathology; Immunology; Internal medicine; Stem cell; Biology; Genetics","score_opus":0.020139170864182276,"score_gpt":0.2911539118828633,"score_spread":0.27101474101868106,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892785587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937607,0.0025003864,0.00042800288,0.00051377976,0.00012022714,0.0007654917,0.00000785664,0.000026908034,0.0018766142],"genre_scores_gemma":[0.99050486,0.0075210524,0.000988135,0.0006389754,0.000038128048,0.000015446409,0.000009891021,0.00003516198,0.00024832756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973542,0.0004160482,0.0011119727,0.000575748,0.00017808539,0.00036390786],"domain_scores_gemma":[0.998498,0.00044364828,0.00047897472,0.00034621803,0.00009547841,0.00013766717],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007078983,0.00031039858,0.0014113475,0.00020754524,0.000060755978,0.0000030412475,0.00012808327,0.00087723945,0.00014745926],"category_scores_gemma":[0.000010622488,0.0002585908,0.00014326841,0.00017511976,0.0014166879,0.00004759587,0.000026670528,0.00040288692,0.000004494218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007200041,0.0029716054,0.9588764,0.00042947318,0.000095259136,0.00009213803,0.004002323,6.213429e-7,0.01970958,0.0005271911,0.00010428544,0.005991127],"study_design_scores_gemma":[0.028698694,0.010505257,0.58486634,0.00021766438,0.000108721244,0.0005722887,0.00043498777,0.00009043731,0.37197968,0.0017657075,0.00037934474,0.00038084915],"about_ca_topic_score_codex":0.000009011605,"about_ca_topic_score_gemma":0.000032476222,"teacher_disagreement_score":0.37401,"about_ca_system_score_codex":0.00005004194,"about_ca_system_score_gemma":0.000105985186,"threshold_uncertainty_score":0.99998665},"labels":[],"label_agreement":null},{"id":"W2915941540","doi":"10.1016/j.hemonc.2019.02.001","title":"Prediction of Oncotype Dx recurrence score using clinical parameters","year":2019,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Essar Steel Algoma (Canada); Sault Area Hospital; NOSM University","funders":"","keywords":"Progesterone receptor; Simple (philosophy); Oncology; Internal medicine; Medicine; Statistics; Mathematics; Computer science; Gynecology; Breast cancer; Cancer; Estrogen receptor","score_opus":0.07774010668270737,"score_gpt":0.3288963078730097,"score_spread":0.25115620119030235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2915941540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918936,0.006340933,0.0001360171,0.00006934877,0.0006176876,0.00029112116,0.000013980515,0.000011233363,0.0006260948],"genre_scores_gemma":[0.9951025,0.0036824464,0.0008863975,0.00018264276,0.000042777247,0.00001699586,0.00002049215,0.000013060255,0.00005264515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987722,0.00021430299,0.0003575829,0.000396443,0.000060737762,0.00019873971],"domain_scores_gemma":[0.9992871,0.00010579941,0.00022494685,0.00026355946,0.0000674464,0.00005111459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025115116,0.00016080243,0.00043296954,0.00003630706,0.00005950029,0.0000037634454,0.00010200359,0.0003701279,0.000016449143],"category_scores_gemma":[0.0000069641574,0.0001361449,0.00009284904,0.000060712246,0.00029367497,0.0000058960622,0.00006105668,0.00012171793,0.0000060686016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012446791,0.00035350525,0.94251966,0.000059037473,0.0002752228,0.0000060339075,0.0003121768,0.00001595584,0.03912569,0.00011504332,0.00024122161,0.015731782],"study_design_scores_gemma":[0.023734737,0.016840199,0.48796162,0.00029972318,0.00038723266,0.0011189393,0.0036030617,0.00067398,0.43691126,0.0005023962,0.026716545,0.0012503108],"about_ca_topic_score_codex":0.000014539637,"about_ca_topic_score_gemma":0.000010981973,"teacher_disagreement_score":0.454558,"about_ca_system_score_codex":0.000017380231,"about_ca_system_score_gemma":0.00010830141,"threshold_uncertainty_score":0.55518275},"labels":[],"label_agreement":null},{"id":"W3017597775","doi":"10.1016/j.hemonc.2020.04.001","title":"Targeted recruitment of optimal donors for unrelated hematopoietic cell transplantation","year":2020,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; Stem Cell Network; University of Ottawa; Ottawa Hospital; Princess Margaret Cancer Centre; Stemcell Technologies; University of British Columbia","funders":"Canadian Blood Services; University of Ottawa","keywords":"Club; Transplantation; Stem cell; Hematopoietic stem cell transplantation; Haematopoiesis; Hematopoietic cell; Process (computing); Immunology; Biology; Medicine; Cell biology; Internal medicine; Computer science","score_opus":0.05901093002946059,"score_gpt":0.3038925338736823,"score_spread":0.24488160384422172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017597775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663938,0.004479839,0.021174137,0.0020215889,0.00018918586,0.0030946375,0.00005535628,0.0001269841,0.0024644164],"genre_scores_gemma":[0.986807,0.004363457,0.007305138,0.0008636951,0.00003396153,0.00025966697,0.00017020691,0.000051745414,0.00014511697],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979699,0.00019060212,0.00079896493,0.00050197187,0.00016639924,0.0003721504],"domain_scores_gemma":[0.99859184,0.00052132184,0.00031732896,0.00019699009,0.00012319442,0.000249301],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002944831,0.00031054934,0.0009816309,0.00011675969,0.00010972205,0.0000066788994,0.00011066851,0.0005303734,0.00013023311],"category_scores_gemma":[0.000005408606,0.00027374655,0.00017808331,0.00020725364,0.00018651146,0.00006193963,0.000010173949,0.00024225806,0.000021215654],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029255154,0.0026078022,0.022073438,0.016006958,0.0009835627,0.00083616405,0.07284911,0.00022375406,0.8309735,0.008916245,0.0015976095,0.013676729],"study_design_scores_gemma":[0.017191824,0.00498859,0.0010089548,0.00016025707,0.0004907689,0.0009448484,0.0025276658,0.0010710199,0.9658702,0.00014958541,0.0052119535,0.0003843606],"about_ca_topic_score_codex":0.000004286503,"about_ca_topic_score_gemma":0.0000014821898,"teacher_disagreement_score":0.1348967,"about_ca_system_score_codex":0.00003614697,"about_ca_system_score_gemma":0.00015648459,"threshold_uncertainty_score":0.99997145},"labels":[],"label_agreement":null},{"id":"W3027330850","doi":"10.1016/j.hemonc.2020.04.008","title":"Chemotherapy readiness in pediatric oncology","year":2020,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Alberta Children's Hospital","funders":"","keywords":"Urine; Dipstick; Urine specific gravity; Chemotherapy; Medicine; Refractometer; Gold standard (test); Urology; Internal medicine; Materials science","score_opus":0.0443745007052626,"score_gpt":0.3267677309960837,"score_spread":0.2823932302908211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027330850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9262214,0.011475313,0.00010662553,0.05123077,0.00033915538,0.00082712306,0.0000041087696,0.00014811137,0.009647403],"genre_scores_gemma":[0.9523211,0.012326891,0.0006426059,0.03384222,0.00046353013,0.00009173572,0.000013113671,0.000053640877,0.00024517515],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99725604,0.00052192446,0.00078969373,0.00070805656,0.00018854845,0.0005357452],"domain_scores_gemma":[0.99831384,0.0006412013,0.00029023574,0.00031693137,0.00007301523,0.0003647638],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006728204,0.0003470158,0.0014476652,0.00018862163,0.00008971788,0.000009254315,0.00019951873,0.00073857553,0.00025443983],"category_scores_gemma":[0.000028552766,0.00031322494,0.00012847004,0.00046997782,0.00024219869,0.00007646776,0.00005692997,0.0006834174,0.00008691625],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013948235,0.0035878064,0.805475,0.0016369179,0.00034202708,0.002323068,0.05183011,0.000005554944,0.004565951,0.005183164,0.022194473,0.08890769],"study_design_scores_gemma":[0.083194114,0.021158617,0.1921047,0.00016767139,0.0003239898,0.0035788252,0.010680686,0.00043190026,0.023629868,0.0023559346,0.66020316,0.0021705448],"about_ca_topic_score_codex":0.00003614569,"about_ca_topic_score_gemma":0.00007780275,"teacher_disagreement_score":0.6380087,"about_ca_system_score_codex":0.00011893606,"about_ca_system_score_gemma":0.00050424156,"threshold_uncertainty_score":0.999932},"labels":[],"label_agreement":null},{"id":"W3045929969","doi":"10.1016/j.hemonc.2020.07.005","title":"The Risk and Prognosis of COVID-19 Infection in Cancer Patients","year":2020,"lang":"en","type":"review","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Regional Hospital","funders":"","keywords":"Meta-analysis; Coronavirus disease 2019 (COVID-19); Medicine; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Oncology; Virology; Internal medicine; Disease; Infectious disease (medical specialty); Outbreak","score_opus":0.10851786277761712,"score_gpt":0.4418998797513932,"score_spread":0.3333820169737761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3045929969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01912762,0.97651964,0.000005714461,0.0016503752,0.00024491796,0.0022903625,0.00003252554,0.000027864071,0.000100952784],"genre_scores_gemma":[0.008177506,0.99018246,0.000010543502,0.0010864923,0.00005127753,0.00040834793,0.00001638244,0.000028109002,0.000038877413],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974933,0.0008713925,0.0007731828,0.00042698748,0.00011646827,0.00031864044],"domain_scores_gemma":[0.9968817,0.0018396379,0.00071217836,0.00019072586,0.00007170614,0.0003040346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057004864,0.00032275514,0.0021204173,0.00019125591,0.00019483059,0.000008169116,0.000079526246,0.00078909204,0.000020831007],"category_scores_gemma":[0.0001335425,0.00019591817,0.0001601694,0.00030619567,0.0002982385,0.000027403592,0.000054219585,0.0007182837,0.0000033530905],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003217023,0.00021185029,0.17307292,0.01626396,0.00013745016,0.000032744225,0.00086308125,6.155633e-8,2.483817e-7,0.000096992706,0.0004072286,0.8085918],"study_design_scores_gemma":[0.0022382431,0.0016906596,0.004844861,0.0012290344,0.00032052523,0.00009371914,0.00005302772,0.00000394611,0.0000060595717,0.000075474374,0.9892926,0.00015182726],"about_ca_topic_score_codex":0.00074801553,"about_ca_topic_score_gemma":0.0010276557,"teacher_disagreement_score":0.9888854,"about_ca_system_score_codex":0.00029114287,"about_ca_system_score_gemma":0.0020038148,"threshold_uncertainty_score":0.79893106},"labels":[],"label_agreement":null},{"id":"W3088032068","doi":"10.1016/j.hemonc.2020.08.005","title":"Vitamin D baseline levels at diagnosis of breast cancer","year":2020,"lang":"en","type":"review","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Essar Steel Algoma (Canada); Sault Area Hospital","funders":"","keywords":"Baseline (sea); Meta-analysis; Breast cancer; Medicine; Cancer; Oncology; Internal medicine; Political science","score_opus":0.08496568885239694,"score_gpt":0.38945336544232095,"score_spread":0.30448767658992404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088032068","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011112293,0.9934258,0.0000070513893,0.0021460275,0.00026136223,0.0016984326,0.00061791396,0.00005156758,0.0006806411],"genre_scores_gemma":[0.0013311858,0.99488723,0.000108355634,0.000377222,0.0001880597,0.0012266596,0.000047689984,0.0000821038,0.0017514768],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99641275,0.00089234783,0.001038377,0.0007984481,0.00027933982,0.00057875237],"domain_scores_gemma":[0.99632734,0.00209048,0.0006178513,0.0004611071,0.00019954538,0.0003036734],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00060340064,0.00065196975,0.0053992104,0.00026393606,0.0001684278,0.000005395205,0.00025963603,0.0010241641,0.0008939069],"category_scores_gemma":[0.000041192994,0.00044213733,0.00052448746,0.00038507112,0.0007520683,0.000033032004,0.0003150795,0.0007858698,0.000074288444],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022445637,0.00045626133,0.0030839622,0.026653232,0.0014109951,0.00080140744,0.00038060523,4.0313452e-8,0.000026625397,0.000067744266,0.013734944,0.95315975],"study_design_scores_gemma":[0.0022597476,0.0008736966,0.00047050448,0.0048903236,0.00090200163,0.0021574863,0.00012027683,0.0000038023584,0.00028522187,0.000008335319,0.9876852,0.00034341397],"about_ca_topic_score_codex":0.000018345743,"about_ca_topic_score_gemma":0.000034236415,"teacher_disagreement_score":0.97395027,"about_ca_system_score_codex":0.0002896025,"about_ca_system_score_gemma":0.0007580535,"threshold_uncertainty_score":0.99980307},"labels":[],"label_agreement":null},{"id":"W3092483516","doi":"10.1016/j.hemonc.2020.09.001","title":"Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation","year":2020,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Myeloid leukemia; Medicine; Stem cell; Hematopoietic stem cell transplantation; Transplantation; Haematopoiesis; Oncology; Leukemia; Immunology; Internal medicine; Biology; Genetics","score_opus":0.015094147521941147,"score_gpt":0.2650793779736378,"score_spread":0.24998523045169663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092483516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940323,0.0019455508,0.0014769736,0.0010538354,0.00003361359,0.0008937207,0.00003362341,0.000056227225,0.00047411866],"genre_scores_gemma":[0.9905132,0.0070367367,0.0009541845,0.0011557724,0.000014256298,0.000056886314,0.00007284675,0.00004577046,0.00015035963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975274,0.0003122962,0.00066327496,0.000689056,0.00033055796,0.00047737692],"domain_scores_gemma":[0.9982054,0.0005643332,0.00035375258,0.00032094785,0.00022559364,0.00032994762],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016870604,0.0003978258,0.001473294,0.0003008087,0.00015310067,0.000015817079,0.00018711135,0.0004339606,0.0000510328],"category_scores_gemma":[0.0000039480215,0.00029418193,0.0001547729,0.0006174103,0.00039044628,0.00008900559,0.000054106287,0.0003796748,0.00000894562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037087891,0.0002542273,0.97693974,0.0010273255,0.002427787,0.0003710521,0.0050925566,0.000048920112,0.007187066,0.00018257942,0.000045717432,0.0027142689],"study_design_scores_gemma":[0.05740026,0.012325057,0.65785044,0.00019477082,0.008489099,0.00087741006,0.006355482,0.001563465,0.25306997,0.00013010207,0.00035165367,0.0013922633],"about_ca_topic_score_codex":0.000022311906,"about_ca_topic_score_gemma":0.00006321082,"teacher_disagreement_score":0.31908923,"about_ca_system_score_codex":0.0001344494,"about_ca_system_score_gemma":0.0004736626,"threshold_uncertainty_score":0.999951},"labels":[],"label_agreement":null},{"id":"W3131252046","doi":"10.1016/j.hemonc.2021.01.001","title":"Subcutaneous immunoglobulin in allogeneic hematopoietic cell transplant patients","year":2021,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada); Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"CSL Behring","keywords":"Hematopoietic cell; Antibody; Hematopoietic stem cell transplantation; Immunology; Medicine; Haematopoiesis; Transplantation; Biology; Stem cell; Internal medicine; Genetics","score_opus":0.014850172002607326,"score_gpt":0.2536545451135334,"score_spread":0.2388043731109261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131252046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97708106,0.012530821,0.00016829239,0.0005749308,0.00034575502,0.0007896435,0.000019507657,0.00008114548,0.008408871],"genre_scores_gemma":[0.98919225,0.008064314,0.000673558,0.000988145,0.000025220457,0.00008675427,0.00013431041,0.000053555024,0.00078191067],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970668,0.0004288505,0.0008824025,0.00072552776,0.0002534169,0.00064302137],"domain_scores_gemma":[0.9985419,0.00047703346,0.00018418483,0.00044137976,0.00013467904,0.00022085801],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00031927295,0.0004097748,0.0011309849,0.0001886298,0.00012165941,0.000016019454,0.00013927514,0.0006996559,0.00035508125],"category_scores_gemma":[0.0000046104296,0.00037644236,0.00016195592,0.00031327378,0.00019022315,0.000058470083,0.000026633446,0.0004780595,0.0001133651],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057564313,0.006766842,0.8184335,0.0028277782,0.00030760287,0.024618605,0.018154819,0.000017535309,0.109573714,0.0017478176,0.00039701318,0.011398337],"study_design_scores_gemma":[0.04918104,0.005426727,0.078785785,0.0008961642,0.0005193381,0.038364347,0.0046905526,0.0001359883,0.8055797,0.0010180703,0.013585303,0.001816933],"about_ca_topic_score_codex":0.000012711698,"about_ca_topic_score_gemma":0.00004122514,"teacher_disagreement_score":0.73964775,"about_ca_system_score_codex":0.00010536654,"about_ca_system_score_gemma":0.0003437071,"threshold_uncertainty_score":0.99986875},"labels":[],"label_agreement":null},{"id":"W3138897860","doi":"10.1016/j.hemonc.2021.03.003","title":"Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation","year":2021,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Cumulative incidence; Myeloid leukemia; Hematopoietic stem cell transplantation; Hazard ratio; Transplantation; Oncology; Incidence (geometry); Proportional hazards model; Gastroenterology; Confidence interval","score_opus":0.01554791111714027,"score_gpt":0.27554538541022144,"score_spread":0.2599974742930812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138897860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97719914,0.018854832,0.00012448918,0.00061730406,0.00026344493,0.0008946138,0.000046875288,0.000064163134,0.0019351394],"genre_scores_gemma":[0.9676835,0.02879431,0.00037410363,0.00047090766,0.000022168171,0.00012637231,0.00006184418,0.000060866605,0.002405924],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.996795,0.00058476574,0.0010928323,0.00061888533,0.00035981118,0.0005487211],"domain_scores_gemma":[0.9978567,0.00063393713,0.00042229594,0.000583524,0.00029148546,0.00021209737],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050156924,0.00041835313,0.0016386969,0.00026899058,0.000088794055,0.00000756942,0.00021544038,0.0008999336,0.00036034448],"category_scores_gemma":[0.0000038118776,0.00032826044,0.0003100468,0.00039597112,0.00056205504,0.00008852406,0.00005734102,0.0005693786,0.000020972155],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008310652,0.0014475037,0.5043281,0.0017248128,0.0030309686,0.0032100275,0.015859786,0.000014961002,0.44991857,0.000643012,0.0005358702,0.010975732],"study_design_scores_gemma":[0.015393307,0.0021674042,0.061469547,0.00012437753,0.00044321816,0.0023318683,0.0019375118,0.000053155174,0.91395116,0.00016220451,0.0015942825,0.00037196654],"about_ca_topic_score_codex":0.000013681871,"about_ca_topic_score_gemma":0.000010955135,"teacher_disagreement_score":0.4640326,"about_ca_system_score_codex":0.00018130778,"about_ca_system_score_gemma":0.0010478976,"threshold_uncertainty_score":0.999917},"labels":[],"label_agreement":null},{"id":"W3215272198","doi":"10.1016/j.hemonc.2021.09.008","title":"Outcomes of Patients Diagnosed With Chronic Lymphocytic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Tertiary Care Center","year":2021,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hazard ratio; Internal medicine; Hematopoietic stem cell transplantation; Chronic lymphocytic leukemia; Transplantation; Stem cell; Single Center; Total body irradiation; Surgery; Leukemia; Gastroenterology; Oncology; Chemotherapy; Confidence interval; Cyclophosphamide","score_opus":0.011302720513925961,"score_gpt":0.2569414265498929,"score_spread":0.2456387060359669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3215272198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796704,0.01786859,0.000045547185,0.00012286844,0.00020125235,0.000968593,0.00021844811,0.0000590813,0.0008452235],"genre_scores_gemma":[0.9931786,0.0046527325,0.00022254273,0.0006844508,0.000045329747,0.00021173396,0.00040611657,0.00006420915,0.00053428],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967512,0.00041060755,0.0008822642,0.0008797438,0.0004306871,0.000645504],"domain_scores_gemma":[0.997433,0.000954034,0.00029826205,0.0007536062,0.0003016438,0.00025947584],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015899549,0.0004586107,0.0012482922,0.0001438882,0.00011078051,0.000015644557,0.00019846212,0.0005758883,0.00017420333],"category_scores_gemma":[0.000005302898,0.0003422464,0.00019344655,0.00020855365,0.00048571045,0.000085893844,0.00007736016,0.00032595664,0.00003650311],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0253236,0.0015178769,0.8866079,0.0050646025,0.0014380877,0.018913334,0.04752889,0.00011161873,0.00314285,0.000048668688,0.0005367795,0.0097657805],"study_design_scores_gemma":[0.375547,0.004959918,0.29326037,0.0012376538,0.00096971355,0.0027490945,0.009279674,0.0005470971,0.3057549,0.00004870231,0.004285856,0.0013600393],"about_ca_topic_score_codex":0.00017912443,"about_ca_topic_score_gemma":0.00037075166,"teacher_disagreement_score":0.59334755,"about_ca_system_score_codex":0.008075291,"about_ca_system_score_gemma":0.010719792,"threshold_uncertainty_score":0.99990296},"labels":[],"label_agreement":null},{"id":"W4362643962","doi":"10.56875/2589-0646.1044","title":"Managing Sickle Cell Disease in Patients for Whom Blood Transfusion Is Not an Option","year":2023,"lang":"en","type":"review","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor","funders":"","keywords":"Blood transfusion; Medicine; Disease; Intensive care medicine; Internal medicine","score_opus":0.038336307568596774,"score_gpt":0.31851515952181836,"score_spread":0.28017885195322156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362643962","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054535404,0.9403064,0.000042674095,0.00029371754,0.00043274948,0.0038468216,0.00006672556,0.00010599363,0.00036949787],"genre_scores_gemma":[0.0027080714,0.9950058,0.000076680604,0.00046186819,0.000051151495,0.00041806264,0.0003545665,0.000106336694,0.0008174521],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973758,0.00032189875,0.0008380488,0.0007905045,0.00014540799,0.00052834826],"domain_scores_gemma":[0.9987192,0.00026761927,0.000304513,0.00037651503,0.000061107814,0.0002710299],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003523166,0.0005070348,0.0021147218,0.00038096355,0.0002280453,0.000018434519,0.00015077047,0.0012201039,0.000032738415],"category_scores_gemma":[0.0000047463295,0.00039311533,0.00038289226,0.0002769772,0.00016225681,0.00006427513,0.000034029188,0.000594229,0.000036531157],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016226172,0.0027041999,0.0014285117,0.034422766,0.00028487574,0.00023610085,0.001780813,0.000002313026,0.000008722481,0.00021880056,0.0004584948,0.9568318],"study_design_scores_gemma":[0.019428227,0.004283458,0.00023665692,0.0065459292,0.0025459887,0.000072613286,0.00057332736,0.00027481304,0.00008262417,0.00043949138,0.9645857,0.00093116105],"about_ca_topic_score_codex":0.000015361673,"about_ca_topic_score_gemma":0.000011303421,"teacher_disagreement_score":0.96412724,"about_ca_system_score_codex":0.000070010436,"about_ca_system_score_gemma":0.00033766404,"threshold_uncertainty_score":0.99985206},"labels":[],"label_agreement":null},{"id":"W4362644007","doi":"10.56875/2589-0646.1027","title":"Efficacy and Safety of Checkpoint Inhibitors in Clear Cell Renal Cell Carcinoma: A Systematic Review of Clinical Trials","year":2023,"lang":"en","type":"review","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health","funders":"","keywords":"Renal cell carcinoma; Medicine; Clinical trial; Oncology; Internal medicine; Cancer research","score_opus":0.18934356529509228,"score_gpt":0.4355783261040979,"score_spread":0.24623476080900564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362644007","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015279582,0.9723057,0.000002458003,0.00007823454,0.00030194636,0.010561815,0.000038148224,0.000035445704,0.001396645],"genre_scores_gemma":[0.007975259,0.9905538,0.000136259,0.00010245481,0.00009005131,0.00047808455,0.00006884637,0.00011153185,0.00048373968],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9800885,0.008390676,0.00953887,0.0010705162,0.00037530594,0.0005361617],"domain_scores_gemma":[0.9830742,0.009826763,0.005610877,0.0009897719,0.00016928084,0.00032911816],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.013116888,0.00090613065,0.02091942,0.00055173744,0.00005889189,0.000006396214,0.00028183128,0.0017386357,0.00005102083],"category_scores_gemma":[0.00044875842,0.0005898055,0.0016810382,0.0005767987,0.0005408603,0.000034392888,0.00018054123,0.001159917,0.00003661358],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015047896,0.001196653,0.00021541619,0.9779927,0.0004628573,0.00068745174,0.00028188742,5.6165092e-8,0.000034480083,0.000043358068,0.0002748744,0.017305436],"study_design_scores_gemma":[0.027732557,0.011547389,0.00022500589,0.89620227,0.015324085,0.0020490065,0.00045890448,0.000008161736,0.0020043084,0.000033090455,0.043359622,0.0010556096],"about_ca_topic_score_codex":0.000021573458,"about_ca_topic_score_gemma":0.000005412074,"teacher_disagreement_score":0.081790484,"about_ca_system_score_codex":0.00016765571,"about_ca_system_score_gemma":0.0010866001,"threshold_uncertainty_score":0.9996553},"labels":[],"label_agreement":null},{"id":"W4385704450","doi":"10.56875/2589-0646.1111","title":"A Single-center, Real-world Experience of Chronic GVHD Treatment Using Ibrutinib, Imatinib, and Ruxolitinib and its Treatment Outcomes","year":2023,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ruxolitinib; Ibrutinib; Imatinib; Medicine; Oncology; Real world data; Internal medicine; Intensive care medicine; Myelofibrosis; Leukemia; Data science; Computer science; Bone marrow; Chronic lymphocytic leukemia","score_opus":0.0958834157604409,"score_gpt":0.36096196308239636,"score_spread":0.26507854732195546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385704450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99226075,0.0033638864,0.000018512843,0.0003437051,0.00017902261,0.0011733572,0.00003054951,0.00010134502,0.0025288505],"genre_scores_gemma":[0.98457813,0.013985146,0.0003944634,0.00008700762,0.00002839415,0.00015516217,0.000029292101,0.000034473436,0.000707935],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980491,0.0002005946,0.0006354397,0.00052580505,0.0001334978,0.00045558697],"domain_scores_gemma":[0.998551,0.0006991972,0.0002558058,0.00024824965,0.00005191853,0.00019384519],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018214913,0.00036734977,0.0011506502,0.00028704337,0.00015848062,0.000012246963,0.000053546402,0.00024814758,0.00008062298],"category_scores_gemma":[0.0000050535814,0.00027510495,0.00009214304,0.00023843691,0.00029546657,0.00006896303,0.000027055234,0.00008759709,0.000008330415],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023838482,0.003963337,0.75001144,0.0020747043,0.00095770526,0.0012912478,0.05043144,0.0000054822494,0.10794837,0.0042888555,0.00003602843,0.07660755],"study_design_scores_gemma":[0.0807182,0.02673131,0.1365287,0.0009331744,0.0010548634,0.007946475,0.013954703,0.0055612554,0.71304005,0.00031557,0.011682506,0.0015331692],"about_ca_topic_score_codex":0.000077372766,"about_ca_topic_score_gemma":0.00008321937,"teacher_disagreement_score":0.6134827,"about_ca_system_score_codex":0.0002071183,"about_ca_system_score_gemma":0.00017244197,"threshold_uncertainty_score":0.99997014},"labels":[],"label_agreement":null},{"id":"W4403478805","doi":"10.4103/hemoncstem.hemoncstem-d-24-00008","title":"A flow cytometric approach to compare stem cell apoptosis in aplastic anemia and hypoplastic myelodysplastic syndrome","year":2024,"lang":"en","type":"article","venue":"Hematology/Oncology and Stem Cell Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Aplastic anemia; Medicine; Myelodysplastic syndromes; Bone marrow failure; Flow cytometry; Bone marrow; Anemia; Stem cell; Disease; Pathology; Immunology; Internal medicine; Biology; Haematopoiesis","score_opus":0.024691902540688603,"score_gpt":0.26686379861492804,"score_spread":0.24217189607423945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403478805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97527105,0.011115411,0.0072247037,0.0002507662,0.00054351555,0.0014839297,0.000029145647,0.00020044888,0.0038810272],"genre_scores_gemma":[0.9950458,0.0013916059,0.0022901224,0.00027260857,0.00003838971,0.00029080754,0.0000383214,0.00007656947,0.0005557835],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9967927,0.0003109865,0.00082374073,0.0010429337,0.00029796627,0.00073168596],"domain_scores_gemma":[0.9967705,0.0022968107,0.0001072157,0.00032176764,0.00006171119,0.00044198593],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005105471,0.0005343605,0.0013891055,0.0013257851,0.00013749613,0.000057445308,0.00015637059,0.00046516547,0.0000643721],"category_scores_gemma":[0.000010621395,0.0004601911,0.00009753641,0.0013468678,0.0002213035,0.00012469686,0.000054590004,0.0006400022,0.00016284187],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023869505,0.015957892,0.39382252,0.12911324,0.002898785,0.03140195,0.11525126,0.0044209957,0.12527476,0.01760918,0.007264583,0.13311534],"study_design_scores_gemma":[0.095934056,0.03349208,0.18612683,0.011900536,0.005201288,0.22005217,0.03500299,0.24833055,0.12669522,0.0015286778,0.025367292,0.0103683155],"about_ca_topic_score_codex":0.000011067208,"about_ca_topic_score_gemma":0.000011517381,"teacher_disagreement_score":0.24390955,"about_ca_system_score_codex":0.00017061592,"about_ca_system_score_gemma":0.00023481107,"threshold_uncertainty_score":0.999785},"labels":[],"label_agreement":null}]}